SEC Form 4 · accession 0000874015-18-000034
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick R. O'Neil
Officer — SVP Legal & General Counsel
Period of report
Jan 29, 2018
Accepted (ET)
Jan 31, 2018 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 29, 2018 | M | 55 | $10.82 | A | 14,507 | D | |
| Common StockF1 | Jan 29, 2018 | S | 55 | $55.00 | D | 14,452 | D | |
| Common StockF1 | Jan 29, 2018 | M | 300 | $10.82 | A | 14,752 | D | |
| Common StockF1 | Jan 29, 2018 | S | 300 | $55.00 | D | 14,452 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $10.82 | Jan 29, 2018 | M | 55 | D | Jan 2, 2017 | Jan 1, 2020 | Common Stock | 55 | 0 | D |
| Employee Stock Option (right to buy) | $10.82 | Jan 29, 2018 | M | 300 | D | Jan 2, 2017 | Jan 1, 2020 | Common Stock | 300 | 1,400 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 6/30/2017.